Why a leading broker is bullish on these 3 ASX shares

These ASX shares could be heading higher…

| More on:
A man with a wide, eager smile on his face holds up three fingers.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you have room for some new portfolio additions, then it could be worth considering the three ASX shares listed below.

Here's why analysts at Morgans are bullish on these shares:

QBE Insurance Group (ASX: QBE)

Morgans is feeling positive about this insurance giant's shares. It currently has an add rating and $13.70 price target on them.

The broker believes QBE's shares are trading at an attractive level. Particularly given its balance sheet and the outlook for premium increases.

It said: "We see QBE as likely having positive underlying momentum into next year. QBE has been putting through top-line rate increases of around 9%, which should assist margin expansion into FY22. With QBE's balance sheet recently reset, pricing tailwinds evident and the stock relatively inexpensive trading on ~12.9x FY22F PE."

ResMed Inc (ASX: RMD)

Morgans is a fan of ResMed. Its analysts currently have an add rating and $40.80 price target on its shares.

The broker likes ResMed due to its very positive medium to long term outlook, which is being underpinned by its digital platform.

Morgans commented: "While we believe the next few quarters will likely be volatile, as COVID-related demand for ventilators continues to slow and core sleep apnoea volumes gradually lift, nothing changes our medium/longer term view that the company remains well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain."

Sonic Healthcare (ASX:SHL)

Finally, this healthcare share is another that Morgans rates highly. The broker currently has an add rating and $47.05 price target on its shares.

Morgans is positive on Sonic due largely to its belief that COVID testing will remain strong for the foreseeable future. It also notes that its strong balance sheet opens up M&A opportunities.

Its analysts explained: "We see COVID-19 testing continuing into the foreseeable future, with growth potential in COVID serology testing. SHL's global base business is increasingly resilient, benefitting from geographical diversity. Strong B/S (gearing 21.6x; A$1.3bn headroom) opening the door to acquisitions, contracts and JVs [joint ventures]."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: How does Morgans rate these ASX shares?

Morgans has been looking at a couple of popular shares.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Broker Notes

Why this beaten down ASX 200 stock could rise 50%

This stock could be dirt cheap according to analysts at Bell Potter.

Read more »

Man presses green buy button and red sell button on a graph.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: Fortescue, Qantas, and WiseTech shares

Are these popular shares in the buy zone? Let's find out what analysts are saying.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Buy, hold, sell: Breville, Catalyst Metals, and Goodman shares

Let's see what analysts at Morgans are saying about these top stocks.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: Light & Wonder, NAB, and Woodside shares

Morgans has given its verdict on these popular stocks.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Resources Shares

2 ASX mining shares to buy for 2026

Macquarie has buy ratings on this ASX copper mining share and ASX gold mining stock.

Read more »